Table 2 Biochemical and radiological effects and effects on symptoms
No. | 5-HIAA before | 5-HIAA after 2 months | 5-HIAA at follow-up | Effect on tumoursize on CT-scan | Effect on symptoms | Follow-up (months) | Complications |
|---|---|---|---|---|---|---|---|
1 | 1736 | unknown | unknown | unknown | = | 2(†) | no |
2 | 35 | 23 | 23 | progression | ↓ | 4(†) | postembolization syndrome |
3 | 120 | 160 | 42 | progression | = | 7(†) | hepatic failure |
4 | 1924 | 1549 | 1432 | progression | = | 10(†) | no |
5 | 111 | 75 | 123 | progression (after 9 months) | = | 11(†) | postembolization syndrome |
6 | 1662 | 1564 | 2022 | progression | = | 12(†) | no |
7 | 1740 | 1617 | 1604 | progression (after 5 m) | = | 14 | abscess |
8 | 913 | 140 | 566 | regression | ↑ | 14 | postembolization syndrome |
9 | 1961 | 1531 | 2050 | no change | = | 14(†) | postembolization syndrome |
10 | 72 | 33 | 118 | regression | ↑ | 15 | no |
11 | 875 | 720 | 765 | progression | = | 15 | no |
12 | 1529 | 165 | 502 | regression | ↑↑ | 22 | postembolization syndrome |
13a | 2618 | 1458 | 1186 | regression | = | 6* | no |
13b | 1186 | 777 | 1815 | regression | = | 7 | no |
14 | 91 | 6 | 32 | regression | ↑ | 13 | cholestasis |
15 | 277 | 52 | 79 | regression | ↑ | 25 | no |